Peroxisome Proliferator-Activated Receptor-γ: Novel Therapeutic Target Linking Adiposity, Insulin Resistance, and Atherosclerosis

Author： Kepez Alper  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.20, Iss.2, 2006-01, pp. : 121-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor (PPAR)- as a Target for Wound Healing Drugs: What is Possible?

By Tan N.S.   Michalik L.   Desvergne B.   Wahli W.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 8, 2003-01 ,pp. : 523-530

Adis International

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors (PPARs) and the Human Skin: Importance of PPARs in Skin Physiology and Dermatologic Diseases

By Sertznig Pit   Seifert Markus   Tilgen Wolfgang   Reichrath Jörg  

American Journal of Clinical Dermatology, Vol. 9, Iss. 1, 2008-01 ,pp. : 15-31

Adis International

Access to resources Recommend Favorite

Immune Modulation as a Therapeutic Strategy for Atherosclerosis

By  

Current Drug Therapy, Vol. 5, Iss. 4, 2010-11 ,pp. : 288-300

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor Receptor Pre-Ligand Assembly Domain is an Important Therapeutic Target in Inflammatory Arthritis

By Deng Guo-Min  

BioDrugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 23-29

Adis International

Access to resources Recommend Favorite

Acanthosis Nigricans Associated with Insulin Resistance: Pathophysiology and Management

By Hermanns-Lê T.   Scheen A.   Piérard G.E.  

American Journal of Clinical Dermatology, Vol. 5, Iss. 3, 2004-01 ,pp. : 199-203

Adis International

Access to resources Recommend Favorite